These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1635982

  • 1. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
    Rummeny EJ, Peters PE.
    Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
    [Abstract] [Full Text] [Related]

  • 2. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
    Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV.
    Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
    [Abstract] [Full Text] [Related]

  • 3. [Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
    Vogl TJ, Hammerstingl R, Schnell B, Eibl-Eibesfeldt B, Peqios W, Lissner J.
    Bildgebung; 1992 Dec; 59(4):195-9. PubMed ID: 1292771
    [Abstract] [Full Text] [Related]

  • 4. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
    Giovagnoni A, Paci E.
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
    [Abstract] [Full Text] [Related]

  • 5. New contrast agents for imaging the liver.
    Helmberger T, Semelka RC.
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):745-66, vi. PubMed ID: 11694436
    [Abstract] [Full Text] [Related]

  • 6. Contrast-enhanced MR imaging of the pancreas.
    Kettritz U, Semelka RC.
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):87-100. PubMed ID: 8673719
    [Abstract] [Full Text] [Related]

  • 7. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
    Burke C, Alexander Grant L, Goh V, Griffin N.
    Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
    [Abstract] [Full Text] [Related]

  • 8. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
    Mühler A, Clément O, Vexler V, Berthezène Y, Rosenau W, Brasch RC.
    Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
    [Abstract] [Full Text] [Related]

  • 9. [Magnetic resonance tomography in focal diseases of the liver (review)].
    Kholin AV.
    Vestn Rentgenol Radiol; 1990 Jul; (2):59-63. PubMed ID: 2219689
    [Abstract] [Full Text] [Related]

  • 10. [Dynamic MR tomography of intrahepatic tumors].
    Hamm B, Felix R, Wolf KJ.
    Rofo; 1989 Apr; 150(4):434-41. PubMed ID: 2539622
    [Abstract] [Full Text] [Related]

  • 11. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
    De Gaspari A, De Cobelli F, Del Maschio A.
    Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
    [Abstract] [Full Text] [Related]

  • 12. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM, Earls JP.
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [Abstract] [Full Text] [Related]

  • 13. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G, Pavone P, Cardone G, Pietroletti R, Passariello R, Tettamanti E, Musu C, Felder E.
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [Abstract] [Full Text] [Related]

  • 14. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
    Santyr GE.
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
    [Abstract] [Full Text] [Related]

  • 15. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B, Laniado M, Saini S.
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [Abstract] [Full Text] [Related]

  • 16. [Iron oxides as contrast agents for MRI of the liver].
    Van Beers BE, Pringot J, Gallez B.
    J Radiol; 1995 Nov; 76(11):991-5. PubMed ID: 8594187
    [Abstract] [Full Text] [Related]

  • 17. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
    Reimer P, Schneider G, Schima W.
    Eur Radiol; 2004 Apr; 14(4):559-78. PubMed ID: 14986050
    [Abstract] [Full Text] [Related]

  • 18. Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
    Rofsky NM, Weinreb JC.
    Magn Reson Q; 1992 Sep; 8(3):156-68. PubMed ID: 1390058
    [Abstract] [Full Text] [Related]

  • 19. Soluble-type hepatobiliary contrast agents for MR imaging.
    de Haën C, Gozzini L.
    J Magn Reson Imaging; 1993 Sep; 3(1):179-86. PubMed ID: 8428085
    [No Abstract] [Full Text] [Related]

  • 20. Contrast agents for MR imaging of the liver.
    Balci NC, Semelka RC.
    Radiol Clin North Am; 2005 Sep; 43(5):887-98, viii. PubMed ID: 16098345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.